文献速递胃肠外科围术期管理与 ERAS

高心血管风险患者从减重手术中获益更多

High cardiovascular risk patients benefit more from bariatric surgery than low cardiovascular risk patients.
PubMed 文献 · Surg Endosc · 2018-09-17

该回顾性研究纳入2010至2016年1330例减重手术患者,其中360例符合计算10年ASCVD和Framingham风险评分标准。结果显示术后12个月ASCVD与FRS风险均降低,且术前FRS和ASCVD评分与12个月估计BMI减少百分比呈反比关系。

要点

  • 术前FRS每增加1个百分点,12个月%EBMIL减少0.31个百分点(P<0.001)。
  • 术前ASCVD评分每增加1个百分点,12个月%EBMIL减少0.42个百分点。
  • 减重手术后ASCVD和FRS风险均降低,尤其在袖状胃切除和胃旁路术后。

核心结论

  • 减重手术后ASCVD和FRS风险均降低,尤其在LSG和LRYGB术后。
  • 术前FRS和ASCVD评分与12个月%EBMIL呈反比关系。

研究设计与样本

  • 回顾性研究,回顾2010至2016年减重手术病例。
  • 1330例减重患者中360例符合计算10年ASCVD评分和FRS的标准。

主要发现

  • LSG占63.05%,LRYGB占20.55%,修正手术占11.9%,LAGB占4.4%。
  • 女性初始BMI为42.71±7.85 kg/m2,男性为42.72±7.42 kg/m2。
  • 女性12个月%EBMIL为66.51%,男性为60.29%。
  • 男性术前10年ASCVD评分高于女性,12个月随访时男性RRR为34.73%,女性为35.3%。
  • 男性术前FRS为33.13±21.1%,女性为15.71±14.52%,RRR分别为25.8%和32.2%。

关键数值与推荐

  • 术前FRS每增加1个百分点,%EBMIL减少0.31个百分点(P<0.001)。
  • 术前ASCVD评分每增加1个百分点,%EBMIL减少0.42个百分点。

临床怎么用

  • 术前应计算ASCVD和FRS以评估心血管风险。
  • 高心血管风险患者接受减重手术后心血管风险降低更明显。
  • 术前心血管风险越高,12个月体重减少百分比可能越低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Atherosclerotic cardiovascular disease (ASCVD) and Framingham risk scores (FRS) are used to calculate 10-year risk of coronary death, nonfatal myocardial infarction, or fatal/nonfatal stroke. Our goal is to evaluate the association between preoperative cardiovascular risk and weight loss. METHODS: We retrospectively reviewed bariatric surgeries from 2010 to 2016. Patients who met criteria for calculating 10-year ASCVD score and FRS were included. Data collected included baseline demographics, perioperative parameters, and postoperative outcomes at 12 months. Simple linear regression and multiple linear regression models were applied to test influence of individual or multiple factors of interest on 12-month weight loss outcomes. RESULTS: Of 1330 bariatric patients studied, 360 patients met criteria for ASCVD and FRS calculation. Sleeve gastrectomy (LSG) was the most prevalent surgery 63.05%, followed by Roux-en-Y gastric bypass (LRYGB) 20.55%, revision procedures 11.9%, and adjustable gastric banding (LAGB) 4.4%. Initial BMI was 42.71 ± 7.85 kg/m2 for females and 42.72k ± 7.42 kg/m2 for males, with a 12-month percentage of estimated BMI loss (%EBMIL) of 66.51% in females and 60.29% in males. Preoperative 10-year ASCVD score was higher in males than females with a 34.73% relative risk reduction (RRR) in males and 35.3% RRR in females at 12-month follow-up. Regarding FRS, preoperative risk was 33.13 ± 21.1% in males and 15.71 ± 14.52% in females, with an RRR of 25.8% in males and 32.2% in females. Univariate analysis of preoperative FRS and %EBMIL showed that for every percentage unit increase in the patient's preoperative FRS, %EBMIL decreases 0.31 percentile unit (P < 0.001). Furthermore, preoperative ASCVD score is also significantly associated with %EMBIL-for every percentage unit increase in preoperative ASCVD score, %EBMIL decreases 0.42 percentile credits. CONCLUSION: Study results suggest ASCVD and FRS are equally reduced after bariatric surgery, especially after LSG and LRYGB. Moreover, preoperative FRS and ASCVD risk score showed an inversely proportional relationship with %EBMIL loss at 12 months.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Blanco DG, Funes DR, Giambartolomei G, et al. High cardiovascular risk patients benefit more from bariatric surgery than low cardiovascular risk patients. Surg Endosc. 2018. PMID: 30225605. doi:10.1007/s00464-018-6437-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。